AETHLON MEDICAL, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
AETHLON MEDICAL, INC. (AEMD) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$6.35 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-06-10
- AETHLON MEDICAL, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2026 was -$6.35M.
- AETHLON MEDICAL, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$12.42M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2026-03-31 | -$6.35M 10-K · filed 2026-06-10 |
| 2025-03-31 | -$12.42M 10-K · filed 2026-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |